Terms: = Prostate cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Prognosis
11 results:
1. Methylation Subtypes of Primary prostate cancer Predict Poor prognosis.
Wang X; Jordahl KM; Zhu C; Livingstone J; Rhie SK; Wright JL; Grady WM; Boutros PC; Stanford JL; Dai JY
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1473-1482. PubMed ID: 35437583
[TBL] [Abstract] [Full Text] [Related]
2. Unexpected hematologic malignancies after prostatectomy: Case report and literature review.
Karademir B; Kısa E; Özbilen MH; Bildirici Ç; Karabacakoğlu B; Süelözgen T; İlbey YÖ; Küçük Ü; Olgun A
Urologia; 2021 Nov; 88(4):382-385. PubMed ID: 33579183
[TBL] [Abstract] [Full Text] [Related]
3. Ancestry-specific predisposing germline variants in cancer.
Oak N; Cherniack AD; Mashl RJ; ; Hirsch FR; Ding L; Beroukhim R; Gümüş ZH; Plon SE; Huang KL
Genome Med; 2020 May; 12(1):51. PubMed ID: 32471518
[TBL] [Abstract] [Full Text] [Related]
4. Mantle cell lymphoma diagnosed from radical prostatectomy for prostate adenocarcinoma: a case report.
Tvrdíková E; Křen L; Kubolková AS; Pacík D
Cesk Patol; 2019; 55(4):231-234. PubMed ID: 31842554
[TBL] [Abstract] [Full Text] [Related]
5. Predictive factors and the important role of detectable prostate-specific antigen for detection of clinical recurrence and cancer-specific mortality following robot-assisted radical prostatectomy.
García-Barreras S; Rozet F; Nunes-Silva I; Srougi V; Sanchez-Salas R; Barret E; Galiano M; Cathelineau X
Clin Transl Oncol; 2018 Aug; 20(8):1004-1010. PubMed ID: 29243074
[TBL] [Abstract] [Full Text] [Related]
6. [Knockdown of myeloid cell leukemia 1 gene inhibits the proliferation and promotes apoptosis of prostate cancer cells].
Yang X; Wang R; Xu K; Yang F; Chen Y; Zuo Z; Song B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jan; 33(1):62-66. PubMed ID: 28031117
[TBL] [Abstract] [Full Text] [Related]
7. The reduced concentration of citrate in cancer cells: An indicator of cancer aggressiveness and a possible therapeutic target.
Icard P; Lincet H
Drug Resist Updat; 2016 Nov; 29():47-53. PubMed ID: 27912843
[TBL] [Abstract] [Full Text] [Related]
8. A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant cancers.
Karpel-Massler G; Horst BA; Shu C; Chau L; Tsujiuchi T; Bruce JN; Canoll P; Greene LA; Angelastro JM; Siegelin MD
Clin Cancer Res; 2016 Sep; 22(18):4698-711. PubMed ID: 27126996
[TBL] [Abstract] [Full Text] [Related]
9. Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer.
Hu P; Chu GC; Zhu G; Yang H; Luthringer D; Prins G; Habib F; Wang Y; Wang R; Chung LW; Zhau HE
PLoS One; 2011; 6(12):e28670. PubMed ID: 22205960
[TBL] [Abstract] [Full Text] [Related]
10. Aggressiveness of familial prostate cancer.
Kupelian PA; Reddy CA; Reuther AM; Mahadevan A; Ciezki JP; Klein EA
J Clin Oncol; 2006 Jul; 24(21):3445-50. PubMed ID: 16849760
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP.
Lindström S; Wiklund F; Jonsson BA; Adami HO; Bälter K; Brookes AJ; Xu J; Zheng SL; Isaacs WB; Adolfsson J; Grönberg H
Hum Genet; 2005 Dec; 118(3-4):339-47. PubMed ID: 16189707
[TBL] [Abstract] [Full Text] [Related]
